[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayer Ag ADR (BAYRY)

Bayer Ag ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 44,055,300
  • Shares Outstanding, K 3,930,000
  • Annual Sales, $ 51,564 M
  • Annual Income, $ -4,096 M
  • EBIT $ -1,219 M
  • EBITDA $ 1,932 M
  • 60-Month Beta 0.62
  • Price/Sales 0.83
  • Price/Cash Flow 4.99
  • Price/Book 1.45
  • Price/Earnings ttm 8.06
  • Earnings Per Share ttm 1.35
  • Most Recent Earnings $0.18 on 03/04/26
  • Next Earnings Date 05/12/26 [--]
  • Annual Dividend & Yield (Fwd) 0.02 (0.22%)
  • Most Recent Dividend 0.024 on 04/28/26
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.21
  • Number of Estimates 1
  • High Estimate $0.21
  • Low Estimate $0.21
  • Prior Year $0.35
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.5300 +5.22%
on 04/29/26
12.2200 -9.33%
on 04/15/26
-0.9200 (-7.67%)
since 04/13/26
3-Month
10.2500 +8.10%
on 03/04/26
14.8500 -25.39%
on 02/17/26
-2.5000 (-18.41%)
since 02/13/26
52-Week
6.2000 +78.71%
on 05/14/25
14.8500 -25.39%
on 02/17/26
+4.1500 (+59.88%)
since 05/13/25

Most Recent Stories

More News
Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities

Campaign launches with a Walmart community event and food drive in Clovis, CA on May 14 Additional food collection will take place at Luke Bryan Farm Tour stops in Clovis (May 15) and...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

KEY FACTS The Phase III REVEAL study met its primary endpoints demonstrating sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide) positron...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

Perfuse Therapeutics’ investigational lead program shows potential to become one of the first disease-modifying treatments for both Glaucoma and Diabetic Retinopathy (DR) High...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

KEY FACTS Two late-breaking presentations from the landmark OCEANIC-STROKE study will provide new insights into ischemic strokes that occurred during the trial, as well...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing

The Latest Breakthrough Study from Leaps by Bayer and BCG reveals why optimism varies by technology, region, and context, with varying trends in China, Germany, and the US Younger generations...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class

Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new school is dedicated to help improve primary...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

Nelson Ambrogio appointed to lead U.S. pharmaceuticals business, Bayer’s largest pharmaceutical growth market Appointment supports Bayer Pharmaceuticals’ strategy to renew top-line...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative

Bayer challenges industry to redefine canola innovation and reframe canola's future around real, lasting systems.

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris

The social-first campaign humorously tackles extreme wellness trends while showcasing how Ludacris incorporates One A Day ® multivitamins...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)
Bayer Crop Science Launches 2026 Opportunity Scholarship Program

Bayer Crop Science Canada is excited to support the future of Canadian agriculture with its 2026 Bayer Crop Science Opportunity Scholarship. Through the scholarship, students entering post-secondary...

BAYRY : 11.0900 (-1.07%)
BAYZF : 44.7000 (-0.93%)
BAYN : 0.0100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses....

See More

Key Turning Points

3rd Resistance Point 11.5200
2nd Resistance Point 11.4300
1st Resistance Point 11.3200
Last Price 11.0900
1st Support Level 11.1200
2nd Support Level 11.0300
3rd Support Level 10.9200

See More

52-Week High 14.8500
Fibonacci 61.8% 11.5457
Last Price 11.0900
Fibonacci 50% 10.5250
Fibonacci 38.2% 9.5043
52-Week Low 6.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.